Effectiveness- Implementation Trial of the Function-Based Elopement Treatment
Part of paid clinical trials in Atlanta, Georgia.
- Sponsor
- Emory University
- Study ID
- NCT07194083
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 4 Years - 12 Years
- Healthy Volunteers
- Not accepted
Interventions
- Function-Based Elopement Treatment — BEHAVIORALFBET is a structured, caregiver-implemented behavioral intervention targeting elopement in children. It includes: * Psychoeducation and Behavioral Assessment-caregivers receive training on elopement, behavioral principles, and assessment strategies * Functional Analysis Coaching-therapists guide caregivers through a latency-based functional analysis to identify the function of elopement * Individualized Treatment Implementation-caregivers apply a function-based plan using differential reinforcement, providing preferred items/activities contingent on safe behavior * Treatment Modification-therapists support caregivers in adjusting the plan based on child's response. There will be 12 2-hour, caregiver-mediated sessions across 20 weeks Caregivers also learn safety and prevention strategies, including the use of resources like the Big Red Safety Toolkit.
- Treatment as Usual — BEHAVIORALTAU consists of ongoing Applied Behavior Analysis (ABA) services, including caregiver training as it normally exists, provided by the family's Board Certified Behavior Analyst (BCBA), independent of the study protocol. The BCBA determines session frequency, content, and focus based on clinical judgment and the child's individual needs. Topics may include skill acquisition, behavior reduction (including elopement), or other areas deemed relevant to the child's care. The research team does not influence or standardize the TAU content, but will monitor and document the services delivered for descriptive and comparative purposes
Study Details
The goal of this clinical trial is to test whether the Function-Based Elopement Treatment (FBET) can reduce elopement in children aged 4-12 with autism spectrum disorder (ASD), and to assess its feasibility in community-based Applied Behavior Analysis (ABA) clinics. Researchers will evaluate FBET in a single-arm open-label trial in one clinic, followed by a comparison of FBET to treatment as usual (TAU) across at least six ABA clinics to evaluate effectiveness and implementation. The main questions it aims to answer are: * Is it feasible to use FBET in community-based ABA clinics? * Does FBET reduce elopement? * Does FBET lead to greater clinical improvement? Participants will: * Receive 12 sessions of FBET over 20 weeks with trained BCBAs or receive treatment as usual * Complete caregiver assessments at baseline and endpoint * Engage in caregiver training and practice treatment between appointments
Key Dates
- Start date
- Feb 28, 2026
- Status verified
- Dec 2025
- Primary completion
- Oct 31, 2028
- Completion
- Oct 31, 2028
Study Design
- Enrollment
- 50 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Experimental: FBET: Function-Based Elopement TreatmentClinicals randomized to FBET intervention
- Active Comparator: TAU: Treatment as UsualClinics randomized to the TAU intervention.
Primary Outcome Measure
Change in Elopement Questionnaire scores [ Time Frame: Baseline, Mid point (8-10 weeks), End point (20 weeks), follow up (32 weeks) ]
Central Contacts
- Mindy Scheithauer, PhD404-785-9322
- Auscia Williams
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Marcus Autism Center | Atlanta | Georgia | 30329 |
Find similar trials in Atlanta, GA
Related Studies
- Early Diagnostic Response Model (EDRM)Recruiting · Emory University · Atlanta, Georgia
- Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum DisorderPHASE3 · Recruiting · Intra-Cellular Therapies, Inc. · Phoenix, Arizona
- Safety, Tolerability and Pharmacokinetics of Lumateperone in Pediatric Patients With Autism Spectrum DisorderPHASE1 · Recruiting · Intra-Cellular Therapies, Inc. · Miami, Florida
- Harnessing Communication PreferencesRecruiting · Joel E. Ringdahl · Athens, Georgia